114 related articles for article (PubMed ID: 6814144)
1. [Protection of endotoxin-induced disseminated intravascular coagulation in rats by gabexate mesilate].
Yoshikawa T; Furukawa Y; Murakami M; Takemura S; Kondo M
Nihon Ketsueki Gakkai Zasshi; 1982 May; 45(3):633-40. PubMed ID: 6814144
[No Abstract] [Full Text] [Related]
2. Microcirculatory disturbances in endotoxin-induced disseminated intravascular coagulation. The effects of heparin and gabexate mesilate on locomotive and metabolic changes of neutrophils.
Suzuki M; Suematsu M; Miura S; Oshio C; Oda M; Tsuchiya M
Adv Exp Med Biol; 1988; 242():135-41. PubMed ID: 3149869
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of gabexate mesilate against experimental disseminated intravascular coagulation in rats.
Yoshikawa T; Furukawa Y; Murakami M; Takemura S; Kondo M
Haemostasis; 1983; 13(4):262-7. PubMed ID: 6413308
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of pre-disseminated intravascular coagulation state with gabexate mesilate (FOY)].
Wada H; Suzuki H; Deguchi A; Mori Y; Okubo I; Tsuda M; Nagano T; Deguchi K; Shirakawa S
Rinsho Ketsueki; 1986 Dec; 27(12):2243-8. PubMed ID: 3106677
[No Abstract] [Full Text] [Related]
5. [Treatment of disseminated intravascular coagulation (DIC) or pre-DIC with gabexate mesilate (FOY)].
Wada H; Suzuki H; Mori Y; Deguchi A; Oukubo I; Tsuda M; Tanaka I; Deguchi K; Shirakawa S; Minami N
Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):67-73. PubMed ID: 3132518
[No Abstract] [Full Text] [Related]
6. [Complement and disseminated intravascular coagulation].
Kondo M; Furukawa Y; Yoshikawa T; Kato H; Sugino S
Rinsho Byori; 1985 Jun; Spec No 63():46-54. PubMed ID: 3930816
[No Abstract] [Full Text] [Related]
7. Gabexate as a therapy for disseminated intravascular coagulation.
Umeki S; Adachi M; Watanabe M; Yaji S; Soejima R
Arch Intern Med; 1988 Jun; 148(6):1409-12. PubMed ID: 3132124
[TBL] [Abstract][Full Text] [Related]
8. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies.
Minakata D; Fujiwara SI; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Ohmori T; Kanda Y
Int J Hematol; 2019 Feb; 109(2):141-146. PubMed ID: 30536180
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of gabexate mesilate (FOY) on experimental DIC.
Isobe J
Adv Exp Med Biol; 1979; 120B():385-94. PubMed ID: 229708
[TBL] [Abstract][Full Text] [Related]
10. [Thrombosis in various diseases: disseminated intravascular coagulation and thrombosis].
Terada H
Nihon Rinsho; 1986 May; 44(5):1170-7. PubMed ID: 3091885
[No Abstract] [Full Text] [Related]
11. Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis.
Taenaka N; Shimada Y; Hirata T; Nishijima MK; Takezawa J; Yoshiya I; Kambayashi J
Crit Care Med; 1983 Sep; 11(9):735-8. PubMed ID: 6411432
[TBL] [Abstract][Full Text] [Related]
12. A case of liver cirrhosis complicated with endotoxemia and disseminated intravascular coagulation: a case report.
Yajima Y; Otsuki M; Suzuki H; Mori K; Goto Y
Tohoku J Exp Med; 1987 Mar; 151(3):269-74. PubMed ID: 3109073
[TBL] [Abstract][Full Text] [Related]
13. [Disseminated intravascular coagulation (DIC) after artificial valve replacement: especially tricuspid regurgitation].
Satokawa H; Iwaya F; Igari T; Abe T; Hagiwara K; Tanji M; Watanabe M; Midorikawa H; Sato Y; Takase S
Kyobu Geka; 1990 Apr; 43(4):271-5. PubMed ID: 2112659
[TBL] [Abstract][Full Text] [Related]
14. [Disseminated intravascular coagulation (DIC) following open heart surgery and great vessel surgery. The result of early administration of gabexate mesilate (FOY)].
Chihara K; Akiyama F; Shinozaki T; Shimamoto M; Takahashi K; Imura H; Yamazaki F; Kawarazaki S
Kyobu Geka; 1984 Aug; 37(8):606-13. PubMed ID: 6438381
[No Abstract] [Full Text] [Related]
15. [Effective use of camostat mesilate for chronic disseminated intravascular coagulation complicated by thoracoabdominal aortic aneurysm].
Yoneda K; Amano I; Tanaka H; Yagi H; Tsukaguchi N; Morii T; Narita N
Rinsho Ketsueki; 2001 Jan; 42(1):30-4. PubMed ID: 11235131
[TBL] [Abstract][Full Text] [Related]
16. [Synthetic protease inhibitors in the treatment of disseminated intravascular coagulation].
Aramoto H; Saito H; Shigematsu H; Muto T
Nihon Rinsho; 1993 Jan; 51(1):93-8. PubMed ID: 8433532
[TBL] [Abstract][Full Text] [Related]
17. [Thoracic aortic aneurysm with chronic disseminated intravascular coagulation treated successfully with orally administered camostat mesilate, warfarin and aspirin].
Fukuda N; Shimohakamada Y; Nakamori Y; Tominaga T; Shinohara K; Takahashi T; Oeda E; Sato Y
Rinsho Ketsueki; 2002 Mar; 43(3):199-203. PubMed ID: 11979753
[TBL] [Abstract][Full Text] [Related]
18. [The effects of FUT-175 (nafamostat mesilate) on blood coagulation and experimental disseminated intravascular coagulation (DIC)].
Koshiyama Y; Kobori A; Ogihara M; Yokomoto Y; Ohtani K; Shimamura K; Iwaki M
Nihon Yakurigaku Zasshi; 1987 Dec; 90(6):313-20. PubMed ID: 3443413
[TBL] [Abstract][Full Text] [Related]
19. Effects of ticlopidine and aspirin on endotoxin-induced disseminated intravascular coagulation in rats.
Yoshikawa T; Murakami M; Furukawa Y; Takemura S; Kondo M
Thromb Haemost; 1983 Jun; 49(3):190-2. PubMed ID: 6879507
[TBL] [Abstract][Full Text] [Related]
20. Effects of FUT-175, a new synthetic protease inhibitor on endotoxin-induced disseminated intravascular coagulation in rats.
Yoshikawa T; Murakami M; Furukawa Y; Kato H; Takemura S; Kondo M
Haemostasis; 1983; 13(6):374-8. PubMed ID: 6667905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
